October 30, 2017Research

ESCAPE: Changing the way stroke patients are treated

The ESCAPE trial is a testament to the importance of research and innovation in the evolution of treatment options for patients. Our neurointerventional surgeons were key contributors to this landmark clinical trial that demonstrated the benefits of endovascular treatment compared to conventional treatment for patients with acute ischemic stroke. The results were published in the […]

October 30, 2017Research

Apollo™ Onyx™ Delivery Micro Catheter

We participated in a post-market safety study to evaluate the new Apollo Onyx micro catheter. The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Micro Catheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures. Principal Investigator: Richard Bellon, MD For more information […]

October 30, 2017Research

ATLAS: Next Generation Treatment for Intracranial Aneurysms

Safety and Effectiveness of the Treatment of Wide-Neck, Intracranial, Saccular Aneurysms with the Next Generation Neuroform Stent System As part of our ongoing commitment to improving patient outcomes by participating in clinical research, we are proud to participate in a study focused on the safety and effectiveness of the Atlas system. Used in the treatment […]

October 30, 2017Research

Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device

The full name of this study is: Barrel™: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms This single arm study is evaluating the outcomes of treatment with the Barrel VRD device as an adjunctive treatment to coiling for wide neck, intracranial, bifurcating/branching aneurysms […]

October 30, 2017Research

Treating Intracranial Aneurysms with the CODMAN ENTERPRISE® Device

A Prospective, Multi-Center, Single Arm Study to evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System when used in conjunction with Endovascular Coil Embolization in the Treatment of Wide-Necked Saccular Intracranial Aneurysms. This study is currently open to enrollment. National Principal Investigator: Donald Frei, MD For more information about […]

October 29, 2017Featured, Research

Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil (SMART)

This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (SMART), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD). Data for each patient are collected in accordance with the standard of care at each participating hospital through one-year follow-up. Approximately 1,000 patients […]

October 29, 2017Featured, Research

StrokeNet: Developed by the National Institute of Health

StrokeNet, developed by NIH, is the new structure for federal funding of all aspects of stroke research including prevention, acute treatment, and recovery / rehabilitation. The University of Cincinnati has been named as the national coordinating center and there are 25 regional coordinating centers across the United States, including the University of Utah. RIA is […]

October 29, 2017Featured, Research

We Are Committed to Clinical Research

RIA has a rich history of participation in clinical research and innovation dating back to the 1980s.  Many of our physicians believe it is important to contribute to science and advance medicine.  Further, our patients can benefit from access to emerging and novel technology. In recent years, RIA Research has focused on building infrastructure and […]

October 29, 2017Featured, Research

COMPASS Trial: A Direct Aspiration First Pass Technique

Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours. Mechanical thrombectomy, the mechanical removal of blood clots, for AIS patients has been shown in clinical […]

October 29, 2017Featured, Research

Framing Eighteen Coils in Cerebral Aneurysms Trial (FEAT)

FEAT is a prospective, randomized trial comparing the utilization of 0.014-0.0155” coils versus smaller diameter coils in mid-sized aneurysm treatment. The 0.014-0.0155” bare platinum coils (Stryker, Natick, MA) are FDA-approved and in common use at institutions in this country and across the world. Patients between 18 – 80 years of age presenting with ruptured or […]